CollPlant Biotechnologies (CLGN) Total Liabilities (2018 - 2025)

CollPlant Biotechnologies' Total Liabilities history spans 8 years, with the latest figure at $4.7 million for Q4 2025.

  • For Q4 2025, Total Liabilities fell 10.31% year-over-year to $4.7 million; the TTM value through Dec 2025 reached $4.7 million, down 10.31%, while the annual FY2025 figure was $4.7 million, 10.31% down from the prior year.
  • Total Liabilities reached $4.7 million in Q4 2025 per CLGN's latest filing, down from $5.2 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $6.1 million in Q4 2021 to a low of $4.7 million in Q4 2025.
  • Average Total Liabilities over 5 years is $5.5 million, with a median of $5.5 million recorded in 2022.
  • Peak YoY movement for Total Liabilities: increased 5.45% in 2023, then dropped 10.31% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $6.1 million in 2021, then decreased by 10.09% to $5.5 million in 2022, then increased by 5.45% to $5.8 million in 2023, then fell by 9.35% to $5.2 million in 2024, then fell by 10.31% to $4.7 million in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Total Liabilities are $4.7 million (Q4 2025), $5.2 million (Q4 2024), and $5.8 million (Q4 2023).